Vicore Pharma Holding AB (VCRE:NASDAQ) closed at $10.36 on November 13, 2026, down 6.75% on the day. The stock trades 41.8% below its 52-week high of $17.80 and 31.5% above its 52-week low of $7.88. Over the past year, it lost 36.2%. Vicore Pharma Holding AB is part of the Health Care sector.
In 93 trading sessions since July 7, 2026, VCRE closed higher on 37 days (40%). Its best day was October 22, 2026 (+11.21%) and its worst was October 23, 2026 (-9.11%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 2 times.
Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).
Find more stocks like VCRE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.